Proof-of-concept Study for SAR441344 in Relapsing Multiple Sclerosis

Condition:   Multiple Sclerosis
Interventions:   Drug: SAR441344 IV;   Drug: placebo IV;   Drug: SAR441344 SC;   Drug: placebo SC;   Drug: MRI contrast-enhancing preparations
Sponsor:   Sanofi
Active, not recruiting